AlphaYouCC
Schedule 13G filing
Commodore Capital LP disclosed a 7.6% stake in Sagimet Biosciences Inc. (SGMT)
Commodore Capital LP reported owning 7.6% of Sagimet Biosciences Inc. (SGMT) (5,507,752 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G
More SGMT insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.